Xoma | XOMA - Spese Operative





Spese Operative Cambiamento Data
AbbVie USD 10.27B 538M 2026-03
Agenus USD 19.81M 293.94M 2025-12
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Ardelyx USD 120.12M 14.46M 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Celldex Therapeutics USD 87.27M 511.09M 2025-12
Curis USD 9.02M 23.01M 2025-12
Eli Lilly USD 10.02B 285M 2026-03
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Incyte USD 5.62B 4.5B 2026-03
MacroGenics USD 53.32M 13.68M 2025-12
Novartis USD 9.29B 507M 2026-03
Novartis USD 9.8B 23M 2025-12
Pfizer USD 90.1B 77.19B 2026-03
Prothena USD 27.23M 14.95M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Xoma USD 22.84M 1.67M 2024-09